Literature DB >> 24690532

Characterization of the classical biological false-positive reaction in the serological test for syphilis in the modern era.

Fan Liu1, Li-Li Liu2, Xiao-Jing Guo3, Ya Xi3, Li-Rong Lin4, Hui-Lin Zhang3, Song-Jie Huang3, Yu-Yan Chen3, Ya-Feng Zhang3, Qiao Zhang3, Ge-Ling Huang5, Man-Li Tong3, Jie Jiang6, Tian-Ci Yang7.   

Abstract

To characterize the CBFP reaction in the modern era, we analyzed the results of parallel rapid plasma reagin (RPR) and Treponema pallidum particle agglutination (TPPA) tests from a total of 63,765 blood samples obtained at Zhongshan Hospital in the Medical College of Xiamen University from May 2008 to February 2013. Among the 63,765 tested blood samples, 206 (0.32%) had the CBFP reaction. In multivariate analysis, an increased likelihood of the CBFP reaction was associated with female subjects, subjects ≥80years old, and subjects between 16 and 35years old (P<0.05). The CBFP reaction occurred in association with 17 categories of disease, including 60 types of diseases, in the 206 subjects. To our knowledge, a number of these diseases had not been previously reported to be associated with the CBFP in the RPR test, including false labor, megaloblastic anemias, aplastic anemias, redundant prepuce, congenital malformation of heart, and salpingitis. Among the 206 patients with the CBFP reaction, 35 patients were subjected to follow-up for five years. 26 out of 35 these patients were at a 1:1 initial RPR titer, 8 out of 35 patients were at a 1:2 initial RPR titer, and 1 out of 35 patients were at a 1:4 initial RPR titer. 30 subjects had their RPR seroreverted. In our opinion, additional CBFP research using a large sample population will contribute to the identification of additional underlying serious disorders that are not related to syphilis. Such results could be useful for the prediction and diagnosis of these diseases.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biological false positive; Nontreponemal antibody test; Rapid plasma reagin; Syphilis; Treponema pallidum particle agglutination

Mesh:

Year:  2014        PMID: 24690532     DOI: 10.1016/j.intimp.2014.03.011

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

1.  Evaluation of the Vitros Syphilis TPA chemiluminescence immunoassay as a first-line method for reverse syphilis screening.

Authors:  Victoria González; Gema Fernández; Eva Dopico; Nuria Margall; Juliana Esperalba; Carme Muñoz; Elisabeth Castro; Elena Sulleiro; Lurdes Matas
Journal:  J Clin Microbiol       Date:  2015-01-21       Impact factor: 5.948

2.  Frequency and Characteristics of Biological False-Positive Test Results for Syphilis Reported in Florida and New York City, USA, 2013 to 2017.

Authors:  James Matthias; Ellen J Klingler; Julia A Schillinger; Gayle Keller; Craig Wilson; Thomas A Peterman
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

Review 3.  Current Perspectives on Prevention of Mother-to-Child Transmission of Syphilis.

Authors:  Eleonor G Lago
Journal:  Cureus       Date:  2016-03-09

4.  Serological evaluation of antigen Tp0693 for diagnosis of syphilis.

Authors:  Li Zhang; Meixia Deng; Xiaohong Zhang; Weiguo Yin; Wen Liu; Xi Luo; Jie Yang; Fei Chen; Feijun Zhao
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

5.   Comparison and evaluation of Abbott chemiluminescent microparticle immunoassay and ChIVD light-initiated chemiluminescent assay in the detection of Treponema pallidum antibody.

Authors:  Xiaohui Chen; Ruifeng Yang; Yongming Liang; Teng Yuan; Jiansuo Zhou; Tiancheng Wang; Liyan Cui
Journal:  J Clin Lab Anal       Date:  2020-03-04       Impact factor: 2.352

6.  Syphilis Laboratory Guidelines: Performance Characteristics of Nontreponemal Antibody Tests.

Authors:  Susan Tuddenham; Samantha S Katz; Khalil G Ghanem
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

7.  Which Is the Optimum Antigen Concentration for the Venereal Disease Research Laboratory Test of Cerebrospinal Fluid for Neurosyphilis Diagnosis: 10 or 17 μL?

Authors:  Yao Xiao; Wei Li; Qiu-Ling Li; Qiu-Yan Xu; Yang Yang; Tian-Ci Yang; Li-Li Liu; Wei-Ming Gu
Journal:  Front Med (Lausanne)       Date:  2022-04-28

8.  Serological Response Predicts Normalization of Cerebrospinal Fluid Abnormalities at Six Months after Treatment in HIV-Negative Neurosyphilis Patients.

Authors:  Yao Xiao; Man-Li Tong; Li-Rong Lin; Li-Li Liu; Kun Gao; Mei-Jun Chen; Hui-Lin Zhang; Wei-Hong Zheng; Shu-Lian Li; Hui-Ling Lin; Zhi-Feng Lin; Tian-Ci Yang; Jian-Jun Niu
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

9.  The role of routine screening in blood-borne pathogens in Chinese patients undergoing joint arthroplasty.

Authors:  T Cheng; X-L Zhang; J-J Hu; B Li; Q Wang
Journal:  Bone Joint Res       Date:  2017-09       Impact factor: 5.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.